Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bornstein

Showing results (701-710 of 738) with videos related to

Pageof 74
Sort By:
Nature Communications|June 9, 2023
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolaseVinitha N Ragavan, Pramod C Nair, Natalia Jarzebska, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2023
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic ResponsesAlessa Fischer, Simon Kloos, Umberto Maccio, et al.
The Lancet. Diabetes & Endocrinology|July 31, 2023
Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseasesNikolaos Perakakis, Hani Harb, Benjamin G Hale, et al.
Endocrine-Related Cancer|March 24, 2022
Personalized drug testing in human pheochromocytoma/paraganglioma primary culturesKatharina Wang, Ina Schütze, Sebastian Gulde, et al.
Nature Communications|June 8, 2021
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive careClemens Gutmann, Kaloyan Takov, Sean A Burnap, et al.
The Lancet. Diabetes & Endocrinology|October 7, 2021
COVID-19 and metabolic disease: mechanisms and clinical managementCharlotte Steenblock, Peter E H Schwarz, Barbara Ludwig, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2014
Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistanceAntonios Chatzigeorgiou, Tom Seijkens, Barbara Zarzycka, et al.
The Lancet. Diabetes & Endocrinology|September 28, 2023
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)Arvid Sandforth, Reiner Jumpertz von Schwartzenberg, Elsa Vazquez Arreola, et al.
Nature|August 13, 2025
Multiple oestradiol functions inhibit ferroptosis and acute kidney injuryWulf Tonnus, Francesca Maremonti, Shubhangi Gavali, et al.
Human Molecular Genetics|November 26, 2009
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesJohn R B Perry, Michael N Weedon, Claudia Langenberg, et al.
Pageof 74

Showing results (701-710 of 738) with videos related to

Sort By:
Pageof 74
Nature Communications|June 9, 2023
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolaseVinitha N Ragavan, Pramod C Nair, Natalia Jarzebska, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2023
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic ResponsesAlessa Fischer, Simon Kloos, Umberto Maccio, et al.
The Lancet. Diabetes & Endocrinology|July 31, 2023
Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseasesNikolaos Perakakis, Hani Harb, Benjamin G Hale, et al.
Endocrine-Related Cancer|March 24, 2022
Personalized drug testing in human pheochromocytoma/paraganglioma primary culturesKatharina Wang, Ina Schütze, Sebastian Gulde, et al.
Nature Communications|June 8, 2021
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive careClemens Gutmann, Kaloyan Takov, Sean A Burnap, et al.
The Lancet. Diabetes & Endocrinology|October 7, 2021
COVID-19 and metabolic disease: mechanisms and clinical managementCharlotte Steenblock, Peter E H Schwarz, Barbara Ludwig, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2014
Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistanceAntonios Chatzigeorgiou, Tom Seijkens, Barbara Zarzycka, et al.
The Lancet. Diabetes & Endocrinology|September 28, 2023
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)Arvid Sandforth, Reiner Jumpertz von Schwartzenberg, Elsa Vazquez Arreola, et al.
Nature|August 13, 2025
Multiple oestradiol functions inhibit ferroptosis and acute kidney injuryWulf Tonnus, Francesca Maremonti, Shubhangi Gavali, et al.
Human Molecular Genetics|November 26, 2009
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesJohn R B Perry, Michael N Weedon, Claudia Langenberg, et al.
Pageof 74